+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant



Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant



European Journal of Pharmacology 568(1-3): 1-15



The pharmaceutical application of exogenous natural pulmonary surfactant preparations has shown its efficiency in the therapeutical treatment of infants with Respiratory Distress Syndrome. At the same time, the use of these preparations in patients with Acute Respiratory Distress Syndrome, although not still an effective therapy, shows promising results. The analysis of composition, structure and surface activity of some of the different natural surfactant preparations available today for clinical use reveals important differences, a fact that opens horizons in the optimization of new effective formulations in the treatment of the Acute Respiratory Distress Syndrome. The purpose of this review is to carry out an updating of the current models interpreting the role of the main components of pulmonary surfactant as a reference to evaluate the biochemical composition of the preparations of exogenous natural pulmonary surfactant currently in use and their apparent pharmacological effect.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 015139320

Download citation: RISBibTeXText

PMID: 17543939

DOI: 10.1016/j.ejphar.2007.04.035


Related references

Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Pediatric Pulmonology 18(5): 273-278, 1994

Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome. Journal of Maternal-Fetal and Neonatal Medicine 15(3): 167-175, 2004

A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome. Klinische Padiatrie 216(4): 230-235, 2004

Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome. Journal of Perinatal Medicine 37(5): 561-564, 2009

Will exogenous surfactant treat respiratory distress syndrome?. Archives of Disease in Childhood 58(5): 321-323, 1983

Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respiratory distress syndrome: Relation to the degree of respiratory failure and response to exogenous surfactant. European Journal of Pediatrics 156(2): 131-138, 1997

Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome. Critical Care Medicine 28(10): 3383-3388, 2000

Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Drugs 38(4): 591-611, 1989

Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?. Current Opinion in Pediatrics 19(2): 150-154, 2007

Does exogenous surfactant alter pulmonary histology in idiopathic respiratory distress syndrome?. Journal of Pathology 172(Suppl. ): 108A, 1994

Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2000(2): Cd000144, 2000

Progress in the exogenous pulmonary surfactant replacement therapy for the adult respiratory distress syndrome. Zhonghua Yi Xue Za Zhi 75(3): 183-185, 1995

Effects on the pulmonary function after single dose of exogenous pulmonary surfactant in children with acute respiratory distress syndrome. Revista Da Associacao Medica Brasileira 43(2): 145-150, 1997

Molecular aspects of pulmonary surfactant in neonatal respiratory distress syndrome and surfactant replacement therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 54(2): 346-352, 1996

Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. European Journal of Pediatrics 162(7-8): 476-480, 2003